See also this year's filing and all EDGAR filings for this company.
PDF Report 0001621221_2022_Artelo_Biosciences_INC.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001621221, Artelo Biosciences INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 10,317,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 2,039,000 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 279,000 |
| 4 | LiabilitiesCurrent | 526,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 67,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 12,182,579 |
| 9 | ResearchAndDevelopmentExpense | 3,055,713 |
| 10 | remainder_Expenses | 1,127,558 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -44,668,690 |
| 13 | remainder_ComprehensiveNetIncome | 73,343 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 12,635,000 |
| 1 | Liabilities | 593,000 |
| 2 | Expenses | 16,365,850 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 12,042,000 |
| 5 | NetIncome | -61,034,540 |
| 6 | ComprehensiveNetIncome | -60,997,868 |
| 7 | BaseVar | 37,167,942 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -5.25 |
| 9 | EconomicCapitalRatio | 0.155 |
Edgar->Model Mapping
Feature Distribution
Change over Time
